Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System

NCT: NCT03216005 · TERMINATED

NCT IDNCT03216005
StatusTERMINATED
Start Date2017-11-02
Completion2023-10-30

Brief Summary

To evaluate the safety and effectiveness of the BlueLeaf System for the restoration of venous competence for the treatment of symptomatic chronic venous insufficiency (CVI).

Frequently Asked Questions

What is Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System?

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System is a clinical trial registered under NCT03216005. Current status: TERMINATED.

What is the status of NCT03216005?

The current status of NCT03216005 (Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System) is: TERMINATED.

When did Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System start?

Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System started on 2017-11-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑